Bisirna Therapeutics (Suzhou) Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Bisirna Therapeutics (Suzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a) (NCT07551505) | Bisirna Therapeutics (Suzhou) Co., Ltd. | 2026-04-20 |
| A Phase I Clinical Study of VSA012 in Healthy Volunteers (NCT06766929) | Bisirna Therapeutics (Suzhou) Co., Ltd. | 2025-01-20 |
Track Bisirna Therapeutics (Suzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.